The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The structure of erastin-bound xCT–4F2hc complex reveals molecular mechanisms underlying erastin-induced ferroptosis
Open accessAbstract
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by an accumulation of lipid- derived reactive oxygen species (ROS). The small-molecule compound erastin induces ferroptosis via inhibiting the cystine-glutamate antiporter system x c – , which consists of two subunits, namely the light chain xCT and the heavy chain 4F2hc (encoded by the SLC7A11 and SLC3A2 genes, respectively). 1 , 2 , 3 , 4 Recent studies have shown that xCT (SLC7A11) regulates ferroptosis in liver fibrosis, cardiomyopathy, and numerous other pathophysiological processes. 5 , 6 , 7 , 8 The complex formed by xCT and 4F2hc has also been suggested as a possible therapeutic target for cancer, as it is overexpressed in a wide variety of cancer types; moreover, inhibiting xCT impairs cystine uptake, causing an accumulation of ROS and suppressing tumor growth. 9 , 10 However, the underlying molecular mechanisms remain unknown. Here, we overexpressed and then co-purified human xCT and 4F2hc, finding that they form a stable complex (Fig. 1a ). To test whether this purified complex is functional, we then reconstituted the complex into liposomes and performed a counter-flow assay. We found that the wild-type (WT) xCT–4F2hc complex mediates the exchange of cystine and glutamate — measured as the uptake of 14 C-labeled cystine — and this activity was significantly reduced by the system x c – inhibitors, erastin and sulfasalazine ( Supplementary information , Fig. S1 ). Fig. 1: Cryo-EM structure of the erastin-bound xCT–4F2hc complex and the inhibitory effect of erastin on xCT activity in ferroptosis. a Representative gel filtration purification of the xCT–4F2hc complex. The inset shows a Coomassie blue-stained SDS-PAGE gel under reducing (+DTT) and oxidizing (–DTT) conditions. M, molecular weight marker. The bands corresponding to 4F2hc, xCT, and the disulfide-linked xCT–4F2hc complex are labeled with a triangle, circle, and square, respectively. b , c Cryo-EM map ( b ) and atomic model ( c ) of the erastin-bound xCT–4F2hc complex. d Interaction interfaces between xCT and 4F2hc. The boxed regions (from top to bottom) are shown in e , f and g . e Detailed view of the interactions at the extracellular interface, with the polar interactions shown as red dashed lines. f Detailed view of the hydrophobic interactions between the transmembrane helix in 4F2hc and TM4 in xCT. g Detailed view of the xCT–4F2hc complex at the intracellular side; xCT is bound to two lipid molecules. h Structure of the erastin-bound xCT subunit, with the density for erastin shown in mesh. i Model of the erastin-binding pocket located in the intracellular vestibule of xCT. j The erastin molecule is shown sandwiched between TM domains in xCT; the tail of the erastin molecule is surrounded by a cluster of hydrophobic residues (shown as spheres). k Overlay showing the structure of the TM domains in erastin-bound xCT and erastin-bound LAT1 (PDB ID: 6IRT). l , m Dose-response curves for erastin ( l ) and IKE ( m ) measured in xCT-knockout HT-1080 cells expressing either WT xCT or the indicated xCT mutants; the corresponding IC 50 values are also shown. n Erastin-induced lipid peroxidation was measured using C11-BODIPY in xCT-knockout HT-1080 cells expressing either WT xCT or the indicated xCT mutants, 12 h after treatment with 2 μM erastin or DMSO as a negative control. The corresponding percentage of C11-BODIPY-positive values are shown. o Na + -independent [ 14 C]-cystine uptake was measured in xCT-knockout HT-1080 cells and in cells expressing either WT xCT or the indicated xCT mutants; where indicated, the cells were pretreated for 2 h with either 4 μM erastin or DMSO. In l , m *** P < 0.001 vs WT (one-way ANOVA); in o , * P < 0.05, *** P < 0.001, and n.s., not significant ( P > 0.05) (Student’s t -test). Full size image
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Wang, W., Green, M., Choi, J. E., Gijón, M., Kennedy, P. D., Johnson, J. K., Liao, P., Lang, X., Kryczek, I., Sell, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1170-y · Cited by 2,880
Self-citationStructure of the human LAT1–4F2hc heteromeric amino acid transporter complex
Yan, R., Zhao, X., Lei, J., & Zhou, Q. (2019) · Nature · doi:10.1038/s41586-019-1011-z · Cited by 358
Self-citation
Cited by
Copper homeostasis and cuproptosis in health and disease
Chen, L., Min, J., & Wang, F. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01229-y · Cited by 1,493
Self-citationThe molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease
Fang, X., Ardehali, H., Min, J., & Wang, F. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00735-4 · Cited by 1,081
Self-citationFerroptosis in cancer: from molecular mechanisms to therapeutic strategies
Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01769-5 · Cited by 890
Self-citationTargeting ferroptosis opens new avenues for the development of novel therapeutics
Sun, S., Shen, J., Jiang, J., Wang, F., & Min, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01606-1 · Cited by 608
Self-citationTargeting glutamine metabolism as a therapeutic strategy for cancer
Jin, J., Byun, J.-K., Choi, Y.-K., & Park, K.-G. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00971-9 · Cited by 550
Metadata
- Authors
- Yan, R., Xie, E., Li, Y., Li, J., Zhang, Y., Chi, X., Hu, X., Xu, L., Hou, T., Stockwell, B. R., Min, J., Zhou, Q., & Wang, F.
- Venue
- Cell Research
- Published
- 2022-03-29
- Volume
- 32
- Issue
- 7
- Pages
- 687-690
- ISSN
- 1001-0602 (ISSN-L)
- 1748-7838
- OpenAlex
- W4220655281
- Cited by
- 182
- References
- 3
- FWCI
- 21.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The structure of erastin-bound xCT–4F2hc complex reveals molecular mechanisms underlying erastin-induced ferroptosis. https://app.cochat.ai/papers/10.1038/s41422-022-00642-w
- The paper
- Yan, R., Xie, E., Li, Y., Li, J., Zhang, Y., Chi, X., Hu, X., Xu, L., Hou, T., Stockwell, B. R., Min, J., Zhou, Q., & Wang, F. (2022). The structure of erastin-bound xCT–4F2hc complex reveals molecular mechanisms underlying erastin-induced ferroptosis. Cell Research. https://doi.org/10.1038/s41422-022-00642-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.